News - Merck & Co, GlaxoSmithKline

Filter

Current filters:

Merck & CoGlaxoSmithKline

Popular Filters

1 to 25 of 26 results

Cost is preventing boys receiving anti-cancer vaccine for HPV

Cost is preventing boys receiving anti-cancer vaccine for HPV

13-02-2014

While national health systems have been pushing to increase the human papillomavirus (HPV) vaccine uptake…

CervarixEuropeGardasilGlaxoSmithKlineHealthcareMerck & CoPharmaceuticalUSAVaccines

Approval of proposals for atomoxetine, sugammadex and to fund baclofen injection in New Zealand

Approval of proposals for atomoxetine, sugammadex and to fund baclofen injection in New Zealand

13-01-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of proposals to amend…

Asia-PacificBridionEli LillyFinancialGlaxoSmithKlineHealthcareLioresal IntrathecalMerck & CoNeurologicalNew ZealandPharmaceuticalStrattera

Merck & Co trialing MK-3475 with GSK’s pazopanib in renal cancer

Merck & Co trialing MK-3475 with GSK’s pazopanib in renal cancer

18-12-2013

US pharma giant Merck & Co says it has initiated a clinical trial to evaluate the combination of the…

GlaxoSmithKlineMerck & CoMK-3475OncologyPazopanib TabletsPharmaceuticalResearch

Pharma figures high in EU R&D Investment Scoreboard, but led by US firms

19-11-2013

Though not topping the league table, the pharmaceutical industry had a number of drugmakers among the…

EuropeFinancialGlaxoSmithKlineJohnson & JohnsonMerck & CoNorth AmericaNovartisPfizerPharmaceuticalResearchRocheSanofi

Merck’s new HPV vaccine could rejuvenate market, says GlobalData

Merck’s new HPV vaccine could rejuvenate market, says GlobalData

18-11-2013

Despite being hampered both by apathy and resistance in recent years, the human papillomavirus (HPV)…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalV503VaccinesWomen's Health

Uptake of HPV vaccines must increase to reap rewards

Uptake of HPV vaccines must increase to reap rewards

08-11-2013

Here's our take on the week's top stories.

CervarixGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalVaccines

Morningstar analysts find GlaxoSmithKline has strongest pipeline

Morningstar analysts find GlaxoSmithKline has strongest pipeline

06-11-2013

Morningstar, an independent Chicago-based investment research firm, recently published the November 2013…

AbbVieAstraZenecaBayerFinancialGlaxoSmithKlineMerck & CoPharmaceuticalResearchSanofi

Aspen Pharma reports rise in profits from new product launches

11-09-2013

South Africa's leading drugmaker Aspen Pharmacare (APN: SJ) has released financial results which show…

ArixtraAspen PharmacareFinancialFraxiparineGlaxoSmithKlineMerck & CoPharmaceuticalRest of the World

Slow uptake of HPV vaccine in USA "risks health of next generation"

29-07-2013

US human papillomavirus (HPV) vaccination rates in girls aged 13-17 years failed to increase between…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoNorth AmericaPharmaceuticalVaccines

Japan vaccines briefs: Gardasil and Cervarix; Daiichi Sankyo files NDA

21-06-2013

The Japanese Ministry of Health, Labor and Welfare has decided to withdraw its recommendation for a vaccination…

Asia-PacificCervarixDaiichi SankyoGardasilGlaxoSmithKlineMerck & CoPharmaceuticalRegulationVaccinesWomen's Health

Global asthma market to reach 159 million lifetime cases by 2022

16-06-2013

Over 300 million people suffer from asthma, which translates to a drug market worth over $15 billion.…

GlaxoSmithKlineGlobalMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySeretideSingulair

Merck & Co's Gardasil and GSK's Cervarix to be available to developing countries via UNICEF tender

09-05-2013

A new record low price for human papillomavirus (HPV) vaccines will help ensure millions of girls in…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalPricingRest of the World

GSK returns IPX066 rights to Impax; Merck & Co and Pfizer link up on diabetes drug

30-04-2013

US biotech firm Impax Laboratories (Nasdaq: IPXL) saw its shares fall 2% to $17.32 in premarket trading,…

BiotechnologyDiabetesertugliflozinGlaxoSmithKlineImpax LaboratoriesIPX066LicensingMerck & CoNeurologicalPfizerPharmaceuticalResearch

Adult vaccines market controlled by GSK and Merck

15-04-2013

The adult vaccines market has been forecast to increase at a compound annual growth rate (CAGR) of 5.6%…

CervarixGardasilGlaxoSmithKlineMarkets & MarketingMerck & CoPfizerPharmaceuticalPrevnarVaccines

Five new drugs for myelodysplastic syndromes set to launch by 2018

10-02-2013

Through 2018, five new drugs will launch for the treatment of myelodysplastic syndromes (MDS), three…

BaxterCyclacelEstybonEuropeGlaxoSmithKlineMarkets & MarketingMerck & CoNorth AmericaOncologyOnconova TherapeuticsPharmaceuticalResearchRevoladesapacitabineZolinza

GAVI Alliance funds vaccines for cervical cancer in developing countries

08-02-2013

More than 180,000 girls in eight developing countries are set to receive protection against the leading…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoPharmaceuticalRest of the WorldVaccinesWomen's Health

Asthma preventive drugs market led by GlaxoSmithKline's Advair

26-11-2012

The asthma preventive drugs market has been forecast to increase at a compound annual growth rate (CAGR)…

AdvairAstraZenecaGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalRespiratory and PulmonarySingulairSymbicort

GlaxoSmithKline readies for filing of diabetes drug albiglutide on positive final data

12-07-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says that positive data from the Phase III Harmony 8 study…

albiglutideDiabetesGlaxoSmithKlineJanuviaMerck & CoPharmaceuticalRegulationResearch

Price and Preferred Tier main consideration of US physicians in intent to prescribe COPD drugs

12-04-2012

US physicians are eager to prescribe Relovair (fluticasone furoate and vilanterol (FF/VI), being developed…

DuleraGlaxoSmithKlineMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalRelovairRespiratory and PulmonaryTheravance

US ANDAs filed for generic Beyaz, Isentress and Epivir

12-01-2012

The US Food and Drug Administration says that Abbreviated New Drug Applications have been received by…

Anti-viralsBayerBeyazEpivirGenericsGlaxoSmithKlineIsentressMerck & CoPharmaceuticalRegulationReproductive

UK government to switch from Cervarix to Gardasil for HPV vaccination

25-11-2011

As of next September, a different vaccine will be used in the HPV vaccination program to protect girls…

CervarixEuropeGardasilGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalPricingSanofiSanofi Pasteur MSDVaccinesWomen's Health

Hepatitis B vaccines market forecast to show moderate growth until 2018

03-11-2011

The global hepatitis B vaccines market is estimated to be worth $997.0 million in 2010, and is forecast…

Anti-viralsGlaxoSmithKlineMarkets & MarketingMerck & CoPharmaceuticalVaccines

Cancer vaccines market set to see change, will grow to over $9 billion by 2018

24-10-2011

The global cancer vaccines market in seven key markets (the USA, France, Germany, Italy, Spain, UK and…

CervarixDendreonGardasilGlaxoSmithKlineGlobalMarkets & MarketingMerck & CoOncologyPharmaceuticalProvengeVaccines

1 to 25 of 26 results

Back to top